VSee Health, Inc. (VSEE)
OTCMKTS · Delayed Price · Currency is USD
0.0160
-0.0060 (-27.27%)
At close: Aug 28, 2026
VSee Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15.81 | 14.62 | 10.42 | 5.77 | 6.38 | 7.34 | |
Revenue Growth | 69.21% | 40.27% | 80.74% | -9.59% | -13.08% | 7.83% |
Cost of Revenue | 8.94 | 7.26 | 3.24 | 1.93 | 1.54 | 1.41 |
Gross Profit | 6.86 | 7.36 | 7.18 | 3.83 | 4.84 | 5.92 |
Selling, General & Admin | 17.7 | 16.94 | 11.86 | 5.62 | 6.3 | 5.67 |
Operating Expenses | 17.7 | 16.94 | 11.86 | 5.62 | 6.3 | 5.67 |
Operating Income | -10.84 | -9.58 | -4.68 | -1.79 | -1.46 | 0.25 |
Interest Expense | -2.07 | -2.81 | -0.21 | -0.19 | -0.03 | - |
Other Non Operating Income (Expenses) | -0.87 | -2.07 | 3.66 | 0.07 | 0.09 | 0 |
EBT Excluding Unusual Items | -13.77 | -14.47 | -1.23 | -1.91 | -1.4 | 0.25 |
Merger & Restructuring Charges | - | - | -0.79 | -0.09 | -0.22 | - |
Impairment of Goodwill | - | - | -56.68 | - | - | - |
Other Unusual Items | 0.32 | -0.18 | -0.65 | 0.11 | - | 0.13 |
Pretax Income | -13.46 | -14.64 | -59.34 | -1.89 | -1.62 | 0.39 |
Income Tax Expense | 0.06 | 0.07 | -1.64 | 1.84 | -0.69 | 0.11 |
Earnings From Continuing Operations | -13.51 | -14.71 | -57.7 | -3.73 | -0.93 | 0.28 |
Minority Interest in Earnings | - | - | - | -0.04 | 0.09 | 0.2 |
Net Income | -9.89 | -14.71 | -57.7 | -3.76 | -0.84 | 0.48 |
Net Income to Common | -9.89 | -14.71 | -57.7 | -3.76 | -0.84 | 0.48 |
Net Income Growth | - | - | - | - | - | 83.83% |
Shares Outstanding (Basic) | 38 | 20 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 38 | 20 | 10 | 10 | 10 | 10 |
Shares Change | 136.30% | 97.23% | 2.15% | - | 0.53% | 0.99% |
EPS (Basic) | -0.26 | -0.73 | -5.65 | -0.38 | -0.08 | 0.05 |
EPS (Diluted) | -0.26 | -0.73 | -5.65 | -0.38 | -0.08 | 0.05 |
EPS Growth | - | - | - | - | - | 82.03% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.34 | -3.48 | -5.84 | -0.64 | -0.83 | -0.46 |
Free Cash Flow Per Share | -0.17 | -0.17 | -0.57 | -0.06 | -0.08 | -0.05 |
Gross Margin | 43.43% | 50.32% | 68.87% | 66.47% | 75.81% | 80.74% |
Operating Margin | -68.56% | -65.55% | -44.94% | -30.99% | -22.96% | 3.44% |
Profit Margin | -62.59% | -100.65% | -553.69% | -65.26% | -13.11% | 6.49% |
Free Cash Flow Margin | -40.09% | -23.78% | -56.08% | -11.05% | -12.95% | -6.27% |
EBITDA | -8.25 | -7 | -3.36 | -1.79 | - | - |
EBITDA Margin | -52.21% | -47.85% | -32.23% | -30.98% | - | - |
D&A For EBITDA | 2.58 | 2.59 | 1.32 | 0 | - | - |
EBIT | -10.84 | -9.58 | -4.68 | -1.79 | -1.46 | 0.25 |
EBIT Margin | -68.56% | -65.55% | -44.94% | -30.99% | -22.96% | 3.44% |
Effective Tax Rate | - | - | - | - | - | 27.98% |
Revenue as Reported | 15.81 | 14.62 | 10.42 | 5.77 | - | - |